$6.226.31%0.3689
Clearmind Medicine Inc (CMND)
Date: 2026-10-30 16:00O: 5.83H: 6.50L: 5.80C: 6.22Vol: 10.40k
Clearmind Medicine Inc stock is traded at $6.22, with a volume of 10,402. It is up +6.31% in the last 24 hours and down -3.45% over the past month. Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
Previous Close:
$5.85
Open:
$5.83
24h Volume:
10,402
Relative Volume:
1.37
Market Cap:
$3.16M
Revenue:
-
Net Income/Loss:
-$7.90M
P/E Ratio:
-
EPS:
-$185.93
Net Cash Flow:
-$6.29M
1W Performance:
+5.94%
1M Performance:
-3.45%
6M Performance:
-89.09%
1Y Performance:
-99.79%
1-Day Range:
$5.80$6.50
1-Week Range:
$5.80$6.50
52-Week Range:
$5.25$3,108.80
Clearmind Medicine Inc Stock (CMND) Company Profile
Compare CMND vs VRTX, REGN, MRNA, ARGX, ONC
Clearmind Medicine Inc Stock (CMND) Financials Data
Revenue
Chart is being upgraded
This chart will be back soon.
Net Income
Cash Flow
EPS
Clearmind Medicine Inc Stock (CMND) Insider Trading
- HRT FINANCIAL LPJun 15 '2610% Owner
- Transaction
- Sale
- Cost
- $3.32
- #Shares
- 3,183
- Value ($)
- 10,568
- #Shares Total
- 103,492
- HRT FINANCIAL LPJun 12 '2610% Owner
- Transaction
- Sale
- Cost
- $3.36
- #Shares
- 2,102
- Value ($)
- 7,063
- #Shares Total
- 106,675
- HRT FINANCIAL LPJun 11 '2610% Owner
- Transaction
- Sale
- Cost
- $0.12
- #Shares
- 225,191
- Value ($)
- 27,698
- #Shares Total
- 1,838,075
- HRT FINANCIAL LPJun 10 '2610% Owner
- Transaction
- Buy
- Cost
- $0.15
- #Shares
- 2,159,052
- Value ($)
- 330,335
- #Shares Total
- 2,063,266